Your browser doesn't support javascript.
Why the application of IVIG might be beneficial in patients with COVID-19.
Kindgen-Milles, Detlef; Feldt, Torsten; Jensen, Bjoern Erik Ole; Dimski, Thomas; Brandenburger, Timo.
  • Kindgen-Milles D; Department of Anesthesiology, University Hospital Duesseldorf and Medical Faculty, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Feldt T; Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf and Medical Faculty, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Jensen BEO; Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf and Medical Faculty, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Dimski T; Department of Anesthesiology, University Hospital Duesseldorf and Medical Faculty, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Brandenburger T; Department of Anesthesiology, University Hospital Duesseldorf and Medical Faculty, Heinrich Heine University, 40225 Duesseldorf, Germany. Electronic address: timo.brandenburger@med.uni-duesseldorf.de.
Lancet Respir Med ; 10(2): e15, 2022 02.
Article in English | MEDLINE | ID: covidwho-1751531
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulins, Intravenous / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(21)00549-x

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulins, Intravenous / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(21)00549-x